TNF and hepatocellular carcinoma: In BNL and Hepa 1–6 tumor-bearing mice, treatment with TNF (1 μg/mouse), entolimod (1 μg/mouse) or their combination had no observable effect on tumor growth in either HCC mouse model when compared to untreated control groups (S2 Fig).